Futian Pharmaceutical Co., Ltd., commonly referred to as Futian Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 2001, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, particularly in the fields of active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong operational presence across Asia and Europe, Futian Pharma is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of APIs and formulations that cater to various therapeutic areas, setting them apart through rigorous quality control and adherence to international standards. Futian Pharma has achieved notable recognition in the market, positioning itself as a trusted partner for global pharmaceutical companies, and continues to expand its footprint in the competitive landscape of the pharmaceutical sector.
How does Futian Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Futian Pharmaceutical's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Futian Pharmaceutical, headquartered in China (CN), currently does not have publicly available data regarding its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and reducing carbon footprints. While Futian Pharmaceutical has not disclosed its emissions data or commitments, the industry as a whole is moving towards more sustainable practices and setting ambitious targets to mitigate climate impact. As the company progresses, it may consider establishing measurable reduction targets and engaging in initiatives aligned with global climate goals to enhance its sustainability profile.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Futian Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.